JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 12.36% |
| 3 | Healthcare | 9.31% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RESI
3201
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $2.13M | ﹤0.01% |
178,722
+62,293
| +54% | +$675K |
|
|
SINA
3202
DELISTED
Sina Corp
SINA
| $2.12M | ﹤0.01% |
48,903
-41,428
| -46% | -$2.17M |
|
3203
Invesco Large Cap Growth ETF
PWB
$2.45B
| $2.12M | ﹤0.01% |
44,116
-1,828
| -4% | -$87K |
|
3204
Mercury Systems
MRCY
$6.67B
| $2.12M | ﹤0.01% |
31,326
+19,878
| +174% | +$1.38M |
|
3205
CALL
Itaú Unibanco
ITUB
$81.6B
| $2.12M | ﹤0.01% |
309,224
| – | – |
|
3206
Viper Energy
VNOM
$15.2B
| $2.12M | ﹤0.01% |
71,768
-213,447
| -75% | -$6.61M |
|
|
AXAS
3207
DELISTED
Abraxas Petroleum Corp
AXAS
| $2.11M | ﹤0.01% |
96,785
-43,234
| -31% | -$1.05M |
|
|
FLOW
3208
DELISTED
SPX FLOW, Inc.
FLOW
| $2.11M | ﹤0.01% |
52,289
+872
| +2% | +$32.3K |
|
3209
Vanguard FTSE Pacific ETF
VPL
$8.64B
| $2.1M | ﹤0.01% |
31,814
+4,096
| +15% | +$268K |
|
3210
Navios Maritime Partners
NMM
$2.33B
| $2.1M | ﹤0.01% |
160,144
+11,714
| +8% | +$156K |
|
3211
Kontoor Brands
KTB
$4.69B
| $2.1M | ﹤0.01% |
+73,876
| New | +$2.2M |
|
|
NGD
3212
DELISTED
New Gold Inc
NGD
| $2.1M | ﹤0.01% |
2,338,034
+1,087,652
| +87% | +$864K |
|
3213
iShares MSCI Australia ETF
EWA
$1.45B
| $2.09M | ﹤0.01% |
92,393
-1,571,360
| -94% | -$34.4M |
|
3214
CALL
Nektar Therapeutics
NKTR
$2.47B
| $2.08M | ﹤0.01% |
4,000
-2,000
| -33% | -$1M |
|
|
SRDX
3215
DELISTED
Surmodics
SRDX
| $2.07M | ﹤0.01% |
51,898
+9,769
| +23% | +$412K |
|
|
SPPI
3216
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $2.07M | ﹤0.01% |
237,536
+4,697
| +2% | +$42K |
|
|
VPU
3217
Vanguard Utilities ETF
VPU
$8.57B
| $2.06M | ﹤0.01% |
15,605
-45,828
| -75% | -$5.99M |
|
3218
TG Therapeutics
TGTX
$7.46B
| $2.06M | ﹤0.01% |
258,296
-11,702
| -4% | -$88.5K |
|
3219
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $2.06M | ﹤0.01% |
26,833
-12,269
| -31% | -$912K |
|
3220
Heritage Financial
HFWA
$1.22B
| $2.05M | ﹤0.01% |
70,554
+8,750
| +14% | +$263K |
|
3221
AMN Healthcare
AMN
$1.34B
| $2.05M | ﹤0.01% |
38,190
-673
| -2% | -$34.1K |
|
3222
CALL
Newell Brands
NWL
$2.66B
| $2.04M | ﹤0.01% |
+134,600
| New | +$2.01M |
|
3223
Rapid7
RPD
$876M
| $2.04M | ﹤0.01% |
36,618
-31,954
| -47% | -$1.68M |
|
3224
First Trust Cloud Computing ETF
SKYY
$3.31B
| $2.04M | ﹤0.01% |
35,426
+3,008
| +9% | +$177K |
|
3225
CALL
PG&E
PCG
$39.3B
| $2.04M | ﹤0.01% |
85,000
-171,100
| -67% | -$3.44M |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.